Skip to main content
PPCB logo
PPCB
(NASDAQ)
Propanc Biopharma, Inc.
$2.01-- (--)
Loading... - Market loading

Propanc Biopharma (PPCB) Balance Sheet

Assets, liabilities, and shareholders' equity with annual and quarterly data.

Propanc Biopharma Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Propanc Biopharma, Inc. (PPCB) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period EndingJun 2025Jun 2024Jun 2023Jun 2022Jun 2021Jun 2020Sep 2019Jun 2018Jun 2017
Current Assets
Cash and Cash Equivalents0.010.020.010.000.000.070.000.020.07
Cash & Short-Term Investments0.010.020.010.000.000.070.000.020.07
Accounts Receivable0.010.000.000.000.000.000.010.010.01
Inventory0.000.000.000.000.000.000.000.000.00
Other Current Assets8.340.000.010.010.000.000.080.030.00
Total Current Assets8.350.030.020.020.010.070.090.060.08
Non-Current Assets
Property, Plant & Equipment (Net)0.060.020.040.060.000.030.010.010.01
Other Non-Current Assets11.220.030.000.000.000.000.000.000.00
Total Non-Current Assets11.280.050.040.070.010.030.010.010.01
Total Assets19.630.070.060.080.010.100.100.070.10
Current Liabilities
Accounts Payable1.251.210.970.941.040.840.921.160.00
Short-Term Debt1.560.870.530.980.681.501.564.553.40
Accrued Liabilities2.350.890.620.521.310.000.000.000.00
Other Current Liabilities0.400.131.660.150.051.401.931.122.14
Total Current Liabilities5.583.793.163.063.083.744.406.825.54
Non-Current Liabilities
Long-Term Debt0.110.060.020.040.000.000.000.000.00
Other Non-Current Liabilities0.000.000.000.000.000.000.000.000.00
Total Non-Current Liabilities0.150.060.020.040.000.000.000.000.00
Total Liabilities5.733.853.183.113.083.744.406.825.54
Stockholders' Equity
Common Stock0.010.000.010.000.010.260.000.050.00
Retained Earnings-125.62-66.70-64.68-61.56-58.20-55.78-51.04-45.28-38.24
Accumulated Other Comprehensive Income1.321.271.291.231.091.271.070.36-0.14
Treasury Stock0.050.050.050.050.000.000.000.000.00
Additional Paid-in Capital138.2461.7060.2757.3654.0350.6145.6738.1232.93
Shares Outstanding11.610.010.000.000.000.000.000.000.00
Total Stockholders' Equity13.91-3.78-3.12-3.02-3.07-3.64-4.30-6.75-5.44
Total Liabilities & Equity19.630.070.060.080.010.100.100.070.10

Frequently Asked Questions About Propanc Biopharma Balance Sheet

What is a balance sheet?

A balance sheet shows a company's financial position at a specific point in time. It lists total assets (what the company owns), total liabilities (what it owes), and stockholders' equity (the difference). The fundamental equation: Assets = Liabilities + Equity.

What is stockholders' equity?

Stockholders' equity represents the net value belonging to shareholders — total assets minus total liabilities. It includes retained earnings, common stock, and additional paid-in capital. Growing equity over time typically indicates a healthy, profitable business.

What is working capital?

Working capital is current assets minus current liabilities. It measures a company's ability to pay short-term obligations with short-term assets. Positive working capital indicates the company can cover its near-term debts; negative may signal liquidity risk.

What is PPCB's debt level?

Review Propanc Biopharma's total long-term debt and short-term borrowings in the balance sheet table above. Compare debt to equity and total assets to assess leverage and financial risk.

What is book value per share?

Book value per share is total stockholders' equity divided by shares outstanding. It represents the accounting value per share if the company were liquidated. Comparing market price to book value gives the price-to-book (P/B) ratio — a key valuation metric.

These financial metrics are calculated using balance sheet data. Learn how each metric works and screen stocks by them.